Abstract
BackgroundImmune checkpoint blockade is a promising anticancer therapy, whereas the presence of T cells in tumor sites is indispensable for its therapeutic efficacy. To promote the infiltration of T cells...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have